Potential Applications of NRF2 Modulators in Cancer Therapy
The nuclear factor erythroid 2-related factor 2 (NRF2)−Kelch-like ECH-associated protein 1 (KEAP1) regulatory pathway plays an essential role in protecting cells and tissues from oxidative, electrophilic, and xenobiotic stress. By controlling the transactivation of over 500 cytoprotective...
Main Authors: | Emiliano Panieri, Aleksandra Buha, Pelin Telkoparan-Akillilar, Dilek Cevik, Demetrios Kouretas, Aristidis Veskoukis, Zoi Skaperda, Aristidis Tsatsakis, David Wallace, Sibel Suzen, Luciano Saso |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/9/3/193 |
Similar Items
-
Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
by: Pelin Telkoparan-Akillilar, et al.
Published: (2021-03-01) -
The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives
by: Emiliano Panieri, et al.
Published: (2020-05-01) -
Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs
by: Pelin Telkoparan-Akillilar, et al.
Published: (2019-04-01) -
Nrf2 in cancers: A double‐edged sword
by: Shijia Wu, et al.
Published: (2019-05-01) -
The KEAP1–NRF2 System in Cancer
by: Keiko Taguchi, et al.
Published: (2017-05-01)